GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Jianzhijia Pharmaceutical Chain Group Co Ltd (SHSE:605266) » Definitions » Debt-to-Equity

Jianzhijia Pharmaceutical Chain Group Co (SHSE:605266) Debt-to-Equity : 1.29 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Jianzhijia Pharmaceutical Chain Group Co Debt-to-Equity?

Jianzhijia Pharmaceutical Chain Group Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥1,772 Mil. Jianzhijia Pharmaceutical Chain Group Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥1,982 Mil. Jianzhijia Pharmaceutical Chain Group Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥2,913 Mil. Jianzhijia Pharmaceutical Chain Group Co's debt to equity for the quarter that ended in Mar. 2024 was 1.29.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Jianzhijia Pharmaceutical Chain Group Co's Debt-to-Equity or its related term are showing as below:

SHSE:605266' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.1   Med: 0.62   Max: 1.29
Current: 1.29

During the past 10 years, the highest Debt-to-Equity Ratio of Jianzhijia Pharmaceutical Chain Group Co was 1.29. The lowest was 0.10. And the median was 0.62.

SHSE:605266's Debt-to-Equity is ranked worse than
77.66% of 546 companies
in the Healthcare Providers & Services industry
Industry Median: 0.48 vs SHSE:605266: 1.29

Jianzhijia Pharmaceutical Chain Group Co Debt-to-Equity Historical Data

The historical data trend for Jianzhijia Pharmaceutical Chain Group Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jianzhijia Pharmaceutical Chain Group Co Debt-to-Equity Chart

Jianzhijia Pharmaceutical Chain Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.61 0.67 1.14 1.29

Jianzhijia Pharmaceutical Chain Group Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.04 1.10 1.10 1.29 1.29

Competitive Comparison of Jianzhijia Pharmaceutical Chain Group Co's Debt-to-Equity

For the Pharmaceutical Retailers subindustry, Jianzhijia Pharmaceutical Chain Group Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jianzhijia Pharmaceutical Chain Group Co's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Jianzhijia Pharmaceutical Chain Group Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Jianzhijia Pharmaceutical Chain Group Co's Debt-to-Equity falls into.



Jianzhijia Pharmaceutical Chain Group Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Jianzhijia Pharmaceutical Chain Group Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Jianzhijia Pharmaceutical Chain Group Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jianzhijia Pharmaceutical Chain Group Co  (SHSE:605266) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Jianzhijia Pharmaceutical Chain Group Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Jianzhijia Pharmaceutical Chain Group Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Jianzhijia Pharmaceutical Chain Group Co (SHSE:605266) Business Description

Traded in Other Exchanges
N/A
Address
No. 10, Qiying Street, Union Street, Panlong District, Yunnan Province, Kunming, CHN, 650224
Jianzhijia Pharmaceutical Chain Group Co Ltd is engaged in the retail chain business of health products such as medicines, health foods, personal care products, household health products, convenience foods, and daily consumables and provides related professional services.
Executives
Jin Yu Mei Supervisors
Chai Zhi Qi senior management
Shi Yan Chun senior management
Hu Yu Ming senior management
Fang Li Supervisors
Sun Li Supervisors
Jiang Yan Yin senior management
Li Heng Director
Zhang Yun Hong Director
Wang Yan Ping Director
Lan Bo Directors, senior managers
Yan Wen senior management

Jianzhijia Pharmaceutical Chain Group Co (SHSE:605266) Headlines

No Headlines